Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 36 (SLC25A36) is a mitochondrial inner membrane transporter responsible for the import and export of pyrimidine nucleotides (such as cytosine and uracil mono-, di-, and tri-phosphates) and guanine nucleotides, utilizing both uniport and antiport mechanisms[1][2][3][5]. This transporter plays a central role in maintaining mitochondrial nucleotide pools, which are essential for mitochondrial DNA and RNA synthesis and degradation, thus supporting mitochondrial genome maintenance and mitochondrial biogenesis[1][2][3][5]. Genetic defects in SLC25A36 have been shown to cause familial hyperinsulinism/hyperammonemia syndrome due to perturbation of mitochondrial nucleotide availability and metabolic imbalance[1][5]. SLC25A36 is not currently a direct drug target, nor are any drugs or established biomarkers linked to it, but loss of function can lead to metabolic and neurological symptoms[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 36 (SLC25A36).